Hormonal contraceptives: all 330 studies that test it

Page 3 of 4. Open to participants first (27), then studies with results posted, then the rest; newest registration first within each.

• Ulipristal Versus Placebo for Women With Bleeding Induced by MirenaStatus unknownNCT03186586Phase 4
• Application for the Etonogestrel/Ethinyl Estradiol RingStatus unknownNCT03120728Phase 4
• LCS16 vs. COC User Satisfaction and Tolerability StudyCompletedNCT03074045Phase 3
• Quality of Life Outcomes for Ulipristal Acetate and Tranexamic Acid in the Management of Heavy Menstrual BleedingWithdrawnNCT03027973Phase 1
• Treatment of Heavy and/or Prolonged Menstrual Bleeding Without Organic CauseCompletedNCT02943655Phase 3
• Compare Daily Ulipristal Acetate and Combined Oral Contraceptive Effects on Breast Epithelial Cell ProliferationCompletedNCT02922127Phase 1
• The Effect of Norethisterone Enanthate on Recurrent Bacterial VaginosisCompletedNCT02905890Phase 4
• Effectiveness of Levonorgestrel-intrauterine System (LNG-IUS) Versus Depot Medroxyprogesterone Acetate (DMPA) in Treatment of Pelvic Pain in Clinically Diagnosed Endometriotic PatientsCompletedNCT02894151Phase 2
• Apoptotic Signaling Pathways in Rats With Endometrial HyperplasiaCompletedNCT02872818Phase 4
• Study to Assess the Safety, Tolerability, PK, ECG Effects, Food Effect, and Drug-drug Interaction (DDI) of Hormonal Contraceptives of PTI-428 in Healthy Female VolunteersCompletedNCT02846142Phase 1
• Ulipristal Use in Chinese PopulationTerminatedNCT02825719Phase 4
• Pharmacologic Strategies to Use the Levonorgestrel Implant in HIV-infected WomenCompletedNCT02722421Phase 2
• Pharmacokinetic Effect of Evotaz/Microgynon Co-administrationTerminatedNCT02697851Phase 1
• Study of Ulipristal Acetate in Female Patients With Moderately or Severely Impaired Renal Function, Compared With Matched Healthy Female SubjectsCompletedNCT02634437Phase 1
• IVF Outcome Following Treatment With Ulipristal Acetate for Myomatous Uterus After at Least One IVF FailureStatus unknownNCT02601196Phase 4
• Ulipristal Acetate In Disease Charcot-Marie-Tooth Type of 1ATerminatedNCT02600286Phase 2
• Contraception in Women With Sickle Cell DiseaseCompletedNCT02594462Phase 4
• Adenomyosis and Ulipristal AcetateCompletedNCT02587000Phase 2
• The Evidence for Contraceptive Options and HIV Outcomes TrialCompletedNCT02550067Not applicable
• Effect of Concomitant Use of an Antimycotic, an Antibiotic, a Spermicide or Tampons on Pharmacokinetics of Anastrozole and Levonorgestrel Released From Intra-vaginal RingCompletedNCT02545452Phase 1
• Effectiveness of Levonorgestrel-intrauterine System (LNG-IUS) Versus Depot Medroxyprogesterone Acetate (DMPA) in Treatment of Pelvic Pain in Clinically Diagnosed Endometriotic PatientsCompletedNCT02534688Phase 4
• Study of Nuvaring Acceptability, Adherence and Biological Effects Among HIV-negative Women in KenyaCompletedNCT02529683Not applicable
• Clinical Trial the Use of Levonorgestrel-releasing Intrauterine System Versus Etonogestrel Implant in EndometriosisCompletedNCT02480647Phase 4
• A Study to Evaluate the Effect of a Contraceptive Vaginal Ring Delivering Ulipristal Acetate Combined With a Single or Repeated Levonorgestrel on Inhibition of Ovulation, Endometrial Changes and Bleeding Patterns in Normal Cycling WomenStatus unknownNCT02451826Phase 1/2
• The Effect of Post Ablation Medroxyprogesterone Acetate on Endometrial Amenorrhea RatesTerminatedNCT02449161Phase 3
• Effects of Contraceptive Ring on Vaginal Microbiota, HIV Shedding and Local ImmunityCompletedNCT02445989Phase 4
• Endometrial Preparation Before Operative Hysteroscopy in Premenopausal WomenStatus unknownNCT02440750Phase 4
• Ulipristal Acetate 10 mg and Asisted ReproductionTerminatedNCT02425878Phase 3
• Breast Cancer - Anti-Progestin Prevention Study 1CompletedNCT02408770Phase 2
• Safety and Contraceptive Efficacy of an Intravaginal Ring With LNG (Levonorgestrel) Over One Year in Healthy WomenCompletedNCT02403401Phase 3
• Ulipristal Acetate for the Preoperative Management of Hypoechoic Cellular LeiomyomasStatus unknownNCT02361905Phase 4
• The Effect of Ulipristal Acetate (UPA) on Women Ovarian ReserveStatus unknownNCT02361892Phase 4
• Ulipristal Acetate Versus GnRH Analogue Treatment Before Hysteroscopic Resection of Uterine LeiomyomaStatus unknownNCT02361879Phase 4
• Ulipristal Acetate Versus GnRH Analogue and Myometrial PreservationStatus unknownNCT02357563Phase 4
• Endometrial Shedding Prior to Ovulation Induction Pilot StudyCompletedNCT02340013Phase 4
• The Effect of Neoadjuvant DMPA on Glandular Cellularity in Women Awaiting HysterectomyStatus unknownNCT02335203Phase 2
• Sayana® Press Self-injection Study in MalawiCompletedNCT02293694Not applicable
• Clinical Study Investigating the Conversion of the Contraceptive Compound Norethisterone Within the Body Towards the Contraceptive Compound EthinylestradiolCompletedNCT02170038Phase 1
• Microgynon Riociguat Drug Interaction Study in Healthy Postmenopausal WomenCompletedNCT02159326Phase 1
• Levonorgestrel-releasing Intrauterine System in Patients With EndometriosisCompletedNCT02158845Phase 4
• A Bioequivalence Study of Norgestimate /Ethinyl Estradiol (NGM/EE) Tablets Manufactured at 2 Different FacilitiesCompletedNCT02127593Phase 1
• Clinical Trial on the Effects of Progestin-based Contraception in the Genital Tract of HIV-infected and Uninfected WomenCompletedNCT02103660Phase 4
• A Pharmacokinetic Evaluation of Etonogestrel (ENG) Implant and Antiretroviral TherapyCompletedNCT02082652Phase 4
• Study Evaluating Levonorgestrel and Ethinyl Estradiol for Oral ContraceptionStatus unknownNCT02021097Phase 3
• Efficacy Study of Two Continuous Regimens of Oral Daily 5 mg or 10 mg of Ulipristal Acetate (UPA), Versus a Dose of 5.0mg UPA for 24/4 DaysCompletedNCT01953679Phase 2
• Study of a Progestin to Prevent Bleeding Associated With Initiation of Medical Menopause With GnRH AgonistTerminatedNCT01776203Phase 4
• Bleeding Profile With Continuous Hormone Replacement Therapy of Activelle® in Postmenopausal WomenCompletedNCT01705249Phase 4
• Improving the Treatment for Women With Early Stage Cancer of the UterusActive, not recruitingNCT01686126Phase 2
• PGL4001 Efficacy Assessment in Reduction of Symptoms Due to Uterine LeiomyomataCompletedNCT01642472Phase 3
• A Study of Aleglitazar in Combination With Oral Contraceptive Healthy VolunteersCompletedNCT01615354Phase 1
• Investigation of 2 Different Oral Formulations of Estradiol and Norethisterone in Healthy WomenCompletedNCT01596010Phase 1
• Safety,Effectiveness and Acceptability of Sino-implant II in DRCompletedNCT01594632Not applicable
• Assessment of Effects on Ovarian Activity of a Combined Oral Contraceptive Pill When Preceded by the Intake of ellaOne® or Placebo.CompletedNCT01569113Phase 4
• Efficacy and Safety Study of Ulipristal Acetate in Females With Anemia Associated With Uterine LeiomyomaWithdrawnNCT01553123Phase 3
• Influence on the Effect of an Oral Contraceptive Drug After Administration of Liraglutide in Postmenopausal WomenCompletedNCT01508858Phase 1
• Oral Estradiol Valerate Versus Oral Contraceptive Pill in Invitro Fertilization PatientsCompletedNCT01501448Phase 4
• CDB-2914 for Abnormal Uterine Bleeding in Premenopausal WomenWithdrawnNCT01493791Early Phase 1
• Bioavailability of Three Oral Formulations for Hormone Replacement Therapy in Postmenopausal WomenCompletedNCT01477632Phase 1
• Postmenopausal Women,Treatment of Sleep Apnea and Co-morbiditiesCompletedNCT01472315Phase 2/3
• Effect of the Etonogestrel 0.12mg/Ethinyl Estradiol 0.015mg Vaginal Ring on Vaginal Innate and Inflammatory BiomarkersStatus unknownNCT01448291Phase 4
• Is Cerazette Use Before Nexplanon Insertion Predictive for Bleeding Pattern?Status unknownNCT01438736Phase 4
• LCS12 Adolescent StudyCompletedNCT01434160Phase 3
• LCS12 vs. ENG Subdermal Implant (Nexplanon) Discontinuation Rate StudyCompletedNCT01397097Phase 3
• Ulipristal Acetate on Progesterone Levels and Glycodelin-A Endometrial PatternStatus unknownNCT01391845Not applicable
• Pretreatment With Norethindrone Acetate Prior to Levonorgestrel IUS Insertion for Heavy Menstrual BleedingStatus unknownNCT01391052Phase 4
• Prevention of Ovulation Achieved by Single Intra-vaginal Administration of Levogel as Compared to Oral LNGCompletedNCT01286948Phase 1
• Efficacy of Combined Contraceptive Vaginal Ring(NuvaRing)in Women With Idiopathic MenorrhagiaCompletedNCT01266759Not applicable
• PGL4001 Efficacy Assessment in Reduction of Symptoms Due to Uterine Leiomyomata (PEARLIII-extension Study)CompletedNCT01252069Phase 3
• Depot Contraception With and Without Lopinavir/RitonavirWithdrawnNCT01231451Phase 1
• Randomized Control Trial Copper Intrauterine Device and Depo-medroxyprogesterone Acetate (DMPA) of HIV+ Women in MalawiCompletedNCT01191203Not applicable
• PGL4001 Efficacy Assessment in Reduction of Symptoms Due to Uterine LeiomyomataCompletedNCT01156857Phase 3
• Efficacy and Safety Study of Norethindrone Acetate Transdermal Delivery System in ContraceptionCompletedNCT01140217Phase 3
• Comparison of CDB-2914 Versus Placebo in the Prevention of Follicular Rupture Post-luteinizing Hormone (LH) SurgeCompletedNCT01107093Phase 2
• The Effect of Hormonal Contraceptives on Androgens and Glucose MetabolismCompletedNCT01087879Not applicable
• A Study Comparing Mirena and Systemic Progestin for Endometrial HyperplasiaCompletedNCT01074892Phase 4
• Cross-over Study to Prove Bioequivalence Between Two Oral Formulations of Levonorgestrel 1.5 mgCompletedNCT01073904Phase 1
• Drug Interaction Oral Contraceptive Pill (OCP)CompletedNCT01063023Phase 1
• Efficacy of Injectable Contraceptive and Oral Contraceptive Administered After Surgical Treatment of Endometriosis With PainCompletedNCT01056042Phase 4
• Treatment of Hot Flushes Caused by Leuprorelin 11.25 mg in Prostate AdenocarcinomaCompletedNCT01011751Phase 3
• Post Operative Continuous Active Combination Sex Steroids for the Prevention of Recurrent Endometrioma FormationWithdrawnNCT00999479Not applicable
• Medroxyprogesterone Acetate Injection 150 mg/1 mL in Postmenopausal WomenCompletedNCT00830414Phase 1
• Impact of Different Contraceptives on the Immune System of HIV Infected Women in ZambiaCompletedNCT00807625Phase 2
• Study to Evaluate the Safety and Efficacy of Two Contraceptive Vaginal Rings Delivering a Daily Dose of 1500 or 2500 μg of CDB-2914CompletedNCT00791297Phase 2
• A Study to Investigate the Contraceptive Efficacy and Safety of a Subdermal Etonogestrel Implant (Implanon®)(P06473)(COMPLETED)CompletedNCT00725413Phase 4
• A Drug Interaction Study of Folic Acid and Oral Contraceptive Tablets Containing Norgestimate (NGM) /Ethinyl Estradiol (EE) in Healthy Women.CompletedNCT00709982Phase 1
• A Drug Interaction Study of Folic Acid and Oral Contraceptive Tablets Containing Norgestimate (NGM)/Ethinyl Estradiol (EE) in Healthy Women.CompletedNCT00709332Phase 1
• Mirena Efficiency and Tolerability During the First Year of UseCompletedNCT00696202Phase 4
• AZD6140 Oral Contraceptive Interaction StudyCompletedNCT00685906Phase 1
• Oral Contraceptive Efficacy and Body WeightCompletedNCT00662454Phase 4
• An Open-label, Multicentre Study on Preference and Satisfaction of Canadian Women for the Transdermal Contraceptive Patch vs. Previous Primary Contraceptive MethodCompletedNCT00653016Phase 4
• A Trial to Investigate the Effectiveness and Safety of Org 3236 (Etonogestrel) Tablets in Men With Urinary Complaints Suggestive of a Benign Enlargement of the Prostate (304001)(P05806)TerminatedNCT00651807Phase 2
• Mid-luteal Phase Synchronization of Ovarian Folliculogenesis in WomenCompletedNCT00565240Not applicable
• Hormonal Replacement Therapy and Small Artery FunctionCompletedNCT00564031Phase 3
• Birth Control Pill vs Birth Control Patch StudyCompletedNCT00554632Not applicable
• Study Comparing Premarin®/MPA, PREMPRO® and Provera® in Healthy Postmenopausal WomenCompletedNCT00543634Phase 1
• Randomized Trial of Advanced Provision Emergency Contraception Among Women With Gonorrhea or ChlamydiaCompletedNCT00520455Not applicable
• HR-QoL and Sexuality in Mirena Inserted Contraception UsersCompletedNCT00498784Phase 4
• Treatment of Endometriosis With Norethindrone Acetate ( NA) VS. Gonadotropin- Releasing Hormone (GnRH) Agonist (Lupron Depot 11.25 mg)Status unknownNCT00458458Phase 3
• Low Dose Continuous Administration of the Progesterone Receptor Modulator VA2914CompletedNCT00456924Phase 2
• Study Evaluating the Bioequivalence of Levonorgestrel/Ethinyl Estradiol Combinations in Cycling WomenWithdrawnNCT00447863Phase 1

← Hormonal contraceptives overview